Taboola is opening up the monetization engine behind its DeeperDive generative AI product, launching an ad network designed specifically for LLMs, chatbots, and virtual assistants. The move will let ...
Amazon has integrated an AI image generator into its Amazon Shopping app, Mihir Bhanot, director of search at Amazon, wrote in a company blog post. The tool creates images of products based on ...
Berkshire Hathaway agreed on Sunday to buy home builder Taylor Morrison Home Corp. for $6.8 billion in cash. The deal is one of the first big moves by CEO Greg Abel, who succeeded Warren Buffett as ...
Google has frequently emphasized how generative artificial intelligence is making search habits more winding and complex, transforming a channel that remains the core pillar of its business. A ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. SAP's CEO, Christian Klein, speaks at Sapphire. SAP is not just an enterprise software ...
A large part of Airbnb’s Q1 2026 earnings call was dedicated to talking about how the company is using AI tools for coding, customer support, and search. Notably, the company claimed that 60% of the ...
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Lars Peterson joined Investopedia in 2023 as a senior editor of financial product ...
Artificial intelligence is changing how organisations use data. Tasks that once required complex queries and manual analysis can now be done in minutes with modern analytics platforms. Because of this ...
Delivers unified, current, and trusted business context while accelerating the path from AI development to production Developed in collaboration with several enterprise customers, the 4.0 release ...
An ongoing and heated dispute between the Pentagon and Anthropic is raising new questions about how the startup’s technology is actually used inside the US military. In late February, Anthropic ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...